Cyrus Biotechnology

Developer of cloud-based protein-modelling software for drug discovery

placeSeattle, Washington, United States calendar_todayFounded 2014 groups23 employees language cyrusbio.com

Registered entities

Innovation

7 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 26 times.

YearFilings
20232
20244
20253
20263

Social engagement

Social engagement: 4.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Orbimed, Trinity Ventures, Agent Capital, Alumni Ventures.

Investor typeCountShare
Venture capital1185%
Angel & family office18%
Other / undisclosed18%

Recent activity

23 Jul 2025
Event
BIOA Asia-Taiwan
Coming soon